Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Postoperative Analgesia in Thoracic Surgery (ARP-TS)

3 luglio 2026 aggiornato da: Ángel Becerra-Bolaños, MD PhD, Hospital Universitario de Gran Canaria Doctor Negrín

Postoperative Analgesia in Patients Undergoing Thoracic Surgery

Analgesic management in thoracic surgery is a challenge for the anesthesiologist, as thoracotomy is one of the surgical procedures with the most intense postoperative pain, which can impact respiratory function and the patient's subsequent recovery. Epidural analgesia is the gold standard. When epidural catheter placement is not possible, erector spinae plane block is a safe alternative, as the ultrasound target is easily visualized and the injection site is far from the neuraxis, pleura, and major vascular structures. Therefore, this block has been increasingly established in routine clinical practice as an option for patients with additional difficulties or as an alternative technique for those for whom epidural catheter placement is not possible. The main objective of this study is to evaluate postoperative analgesia in patients undergoing elective thoracic surgery.

Design and study population A prospective, observational follow-up study will be conducted. ASA I-III patients undergoing scheduled thoracic surgery between November 1 and December 31, 2025, will be included. Their analgesic management will be based on standard clinical practice.

Panoramica dello studio

Descrizione dettagliata

The gold standard for analgesic management after thoracic surgery is the administration of local anesthetic, with or without opioids, through a catheter placed in the epidural space during the 48 hours following surgery. However, there are situations in which the placement of this catheter is contraindicated (due to patient refusal, coagulation disorders, spinal pathology, etc.) or in which the risk-benefit assessment makes it necessary to consider alternatives (it may lead to hypotension or bradycardia that compromises patients with cardiovascular disease, urinary retention, nerve injury, or spinal hematoma). This has led anesthesiologists to seek alternatives, among which paravertebral block has been investigated, with excellent results, although it is not exempt from the risks associated with a central block and has contraindications similar to those of epidural analgesia. When epidural catheter placement is not possible, erector spinae plane block is a safe alternative, as the ultrasound target is easily visualized and the injection site is far from the neuraxis, pleura, and major vascular structures. Therefore, this block has been increasingly established in routine clinical practice as an option for patients with additional difficulties or as an alternative technique for those for whom epidural catheter placement is not possible. The main objective of this study is to evaluate postoperative analgesia in patients undergoing elective thoracic surgery.

Design and study population A prospective, observational cohort study will be conducted. Patients will be followed from the day of hospital admission (usually 24 hours before surgery, when informed consent will be requested) until hospital discharge.

Perioperative analgesic management will be carried out according to standard clinical practice, after evaluation by the anesthesiologist in charge of intraoperative anesthesia management.

ASA I-III patients scheduled for thoracic surgery at the Doctor Negrín University Hospital of Gran Canaria between November 1 and December 31, 2025, will be included in the study. An estimated 80 patients will be included in this prospective, observational study.

On the day of the procedure, analgesic management will be administered according to the standard clinical practice of the anesthesiologist responsible for the patient's clinical management. The anesthesiologist will be unaware that the patient's perioperative analgesic management will be evaluated by this study. In all patients for whom a regional procedure (epidural catheter or erector spinae plane block) is performed, standard aseptic measures will be followed during the procedure.

The epidural catheter will be placed according to standard clinical practice using the loss-of-resistance technique in the space between the dorsal spinous processes corresponding to the surgical wound site, prior to the patient's anesthesia induction. The anesthesiologist responsible for the patient's perioperative management will decide whether or not to use this catheter to administer analgesics during the intraoperative period or whether to administer intraoperative analgesics with or without the administration of intravenous opioids in combination with non-opioid analgesics.

For patients undergoing an erector spinae plane block, the procedure will be performed using ultrasound with a high-frequency linear ultrasound probe, locating the puncture point 3 cm lateral to the spinous process. The puncture is made at the level of T5, in the craniocaudal plane, using a 50 mm EchoPlex needle, until the needle bevel is seen at the level of the transverse process, immediately anterior to the erector spinae muscle group. At this point, 3 ml of the local anesthetic selected by the anesthesiologist in charge of perioperative management of the patient is injected, visualizing the dissection of the interfascial plane. If adequate dissection of this plane is confirmed during the injection of these 3 ml, the remaining local anesthetic will be injected until the target volume is reached, without exceeding the toxic dose for each patient. 7 Intraoperative anesthetic management will be carried out according to standard clinical practice. At the end of the procedure, after extubation, the patient will be transferred to the Post-Anesthesia Care Unit. Pain will be assessed using a numerical pain scale at 1, 3, 6, 24, and 48 hours postoperatively. Postoperative management will be carried out according to standard clinical practice. The patient's postoperative progress will also be assessed until hospital discharge.

Tipo di studio

Osservativo

Iscrizione (Stimato)

160

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

  • Nome: Ángel Becerra Bolaños, MD PhD
  • Numero di telefono: +34676229025
  • Email: angbecbol@gmail.com

Backup dei contatti dello studio

Luoghi di studio

    • Las Palmas
      • Las Palmas de Gran Canaria, Las Palmas, Spagna, 35002
        • Reclutamento
        • Hospital Universitario de Gran Canaria Doctor Negrín
        • Contatto:
        • Contatto:

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto
  • Adulto più anziano

Accetta volontari sani

No

Metodo di campionamento

Campione non probabilistico

Popolazione di studio

The study will include ASA I-III patients scheduled for thoracic surgery at the Doctor Negrín University Hospital of Gran Canaria between November 1 and December 31, 2025.

Descrizione

Inclusion Criteria:

  • Patients undergoing thoracic surgery between July 1 and October 31, 2020.
  • Age over 18.
  • ASA I-III.
  • Signed informed consent

Exclusion Criteria:

  • ASA IV-V.
  • Chronic opioid treatment or treatment in the Chronic Pain Unit.
  • Intravenous drug abuse.
  • Local anesthetic allergy.
  • Language barrier, cognitive impairment, or inability to participate in clinical assessment during the study.
  • BMI <18 or >35 kg/m2

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

Coorti e interventi

Gruppo / Coorte
Intervento / Trattamento
Epidural analgesia
Patients whose analgesic management will be achieved through an epidural catheter.
Postoperative pain will be assessed using the visual analog pain scale at 1, 3, 6, 24, and 48 hours postoperatively.
The patient's postoperative evolution will be assessed until hospital discharge, in order to define the appearance of postoperative complications classified according to Clavien-Dindo classification.
Erector spinae plane block
Patients whose analgesic management will be achieved through an erector spinae plane block
Postoperative pain will be assessed using the visual analog pain scale at 1, 3, 6, 24, and 48 hours postoperatively.
The patient's postoperative evolution will be assessed until hospital discharge, in order to define the appearance of postoperative complications classified according to Clavien-Dindo classification.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Postoperative pain
Lasso di tempo: 24 postoperative hours
To evaluate the postoperative analgesic effect in patients undergoing elective thoracic surgery according to the Visual Analogue Scale, from 0 to 10.
24 postoperative hours

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Postoperative analgesics consumption
Lasso di tempo: 24 postoperative hours.
To compare the use of rescue analgesic medication in patients receiving any of the different regimens established in routine clinical practice at our hospital for perioperative analgesic management (epidural catheter, paravertebral block, erector spinae plane block).
24 postoperative hours.
Postoperative complications
Lasso di tempo: First postoperative week.
To compare the appearance of postoperative complications in patients receiving any of the different regimens establishedat our hospital for perioperative analgesic management (epidural catheter, paravertebral block, erector spinae).
First postoperative week.

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: Ángel Becerra, MD PhD, Hospital Universitario de Gran Canaria Doctor Negrín

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

15 novembre 2025

Completamento primario (Stimato)

31 dicembre 2026

Completamento dello studio (Stimato)

30 gennaio 2027

Date di iscrizione allo studio

Primo inviato

3 luglio 2026

Primo inviato che soddisfa i criteri di controllo qualità

3 luglio 2026

Primo Inserito (Effettivo)

9 luglio 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

9 luglio 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

3 luglio 2026

Ultimo verificato

1 luglio 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • 2020-339-1

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

INDECISO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Prove cliniche su Gestione del dolore postoperatorio

3
Sottoscrivi